ICON Public Limited Company (ICLR)

Market Cap	17.13B
Revenue (ttm)	8.31B
Net Income (ttm)	747.89M
Shares Out	82.56M
EPS (ttm)	8.99
PE Ratio	23.09
Forward PE	14.26
Dividend	n/a
Ex-Dividend Date	n/a

Volume	703,802
Open	200.88
Previous Close	204.61
Day's Range	200.69 - 210.00
52-Week Range	183.38 - 347.72
Beta	1.20
Analysts	Strong Buy
Price Target	286.67 (+38.15%)
Earnings Date	Feb 19, 2025

About ICLR

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient a...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: May 15, 1998
• Employees: 41,100
• Stock Exchange: NASDAQ
• Ticker Symbol: ICLR
• Website: https://www.iconplc.com

Financial Performance

In 2023, ICLR's revenue was $8.12 billion, an increase of 4.89% compared to the previous year's $7.74 billion. Earnings were $612.34 million, an increase of 21.18%.

Analyst Forecast

According to 9 analysts, the average rating for ICLR stock is "Strong Buy." The 12-month stock price forecast is $286.67, which is an increase of 38.15% from the latest price.

Price Target

$286.67

(38.15% upside)

Analyst Consensus: Strong Buy